MeOmics Precision Medicine
MeOmics has a neural biomarker platform, promising personalised mental healthcare.
MeOmics will capitalise upon the academic research undertaken by the founders at Cardiff University to create an
innovative Precision Psychiatry Platform for improved drug discovery and prediction of optimal drug therapies for individual mental health patients.
We act as an investment opportunity aggregator, collecting hundreds of investment opportunities from across the UK.
If you'd like your events, opportunities and news listed here please join free as an organisation.